logo
calendar6 Oktabr 2024
view33
Main language:Russian

CONDITION OF BLOOD VESSEL ENDOTHELIUM AND RENAL FUNCTION IN PATIENTS WITH CORONARY HEART DISEASE

Field of Science:
pdf

6702d3bb21adb.pdf

PDF

ARTICLE ANNOTATION

quote
Coronary heart disease and chronic renal failure most often occur together, complicating each other. At the root of this phenomenon lies such a common etiological factor as dysfunction of the endothelium of blood vessels. An example is atherosclerosis of blood vessels, prolonged arterial hypertension and other pathophysiological mechanisms. Atherosclerosis first affects peripheral blood vessels, which may initially be asymptomatic. If you do not begin to reduce the cholesterol level in the blood, then atherosclerosis can spread to the coronary and renal arteries, which gives characteristic symptoms for these diseases. In view of all of the above, the joint study of CHD and chronic renal failure is relevant

AUTHORS

A.Alyavi

Ташкентская медицинская академия

SH.Karimov

Ташкентская медицинская академия

Tags

# Coronary heart disease# yurak ishemik kasalligi# Ишемическая болезнь сердца# поражение почек# kidney injury# buyrak zararlanishi

OTHER ARTICLES IN THIS JOURNAL

Rate Article

0
0 ratings
5
4
3
2
1

Article Identifiers

References

1.Belyalov F.I. Treatment of diseases in conditions of comorbidity. 10th ed. Moscow: GEOTAR-Media; 2016. (In Russ.) [БеляловФ.И. Лечениеболезнейвусловияхкоморбидности. Изд. 10-е. Москва: ГЭОТАР-Медиа; 2016].2.Ишемическая болезнь сердца и нарушение функции почек Фарид Исмагильевич Белялов3.Sedlis S.P., Jurkovitz C.T., Hartigan P.M., et al. Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease. Am J Cardiol. 2009; 104: 1647-53. 4.United States Renal Data System. Renal Data System Chapter 4: Cardiovascular Disease in Patients With CKD. Am J Kidn Dis. 2016;67(3):S49-S56.5.Tonelli M., MuntnerP., Lloyd A., et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet. 2012;380(9844): 807-14.6.Gottlieb S.S., McCarter R.J., Vogel R.A. et al. Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial Infarction. N Engl J Med .1998;339:489-97. 7.Fleet J.L., Weir M.A., McArthur E. et al. Kidney Function and Population-Based Outcomes of Initiating Oral Atenolol Versus Metoprolol Tartrate in Older Adults. American Journal of Kidney Diseases. 2014;64:883-91